Return to study ST001251 main page

MB Sample ID: SA091061

Local Sample ID:17_03_t_120
Subject ID:SU001319
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Age Or Age Range:19-27
Weight Or Weight Range:58-92
Height Or Height Range:172-190
Gender:Male
Human Race:Caucasian
Human Trial Type:Prospective randomized open label controlled intervention study
Human Medications:None
Human Prescription Otc:None
Human Smoking Status:Non smoker
Human Alcohol Drug Use:Not in
Human Nutrition:Fasted for 12 hours before the first sample was obtained.
Human Inclusion Criteria:Healthy (normal physical examination, electrocardiography, and routine laboratory values).
Human Exclusion Criteria:Febrile illness during the 2 weeks before the endotoxemia experiment, taking any prescription medication, history of spontaneous vagal collapse, practicing or experience with any kind of meditation, or participation in a previous trial where LPS was administered.

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN002077
Analysis type MS
Chromatography type Reversed phase
Chromatography system Agilent 1290
Column Discovery HS F5-3 (15cm x 2.1 mm,3um) Supelco,Sigma Aldrich)
MS Type ESI
MS instrument type QTOF
MS instrument name Agilent 6540 QTOF
Ion Mode UNSPECIFIED
Units relative abundance

MS:

MS ID:MS001928
Analysis ID:AN002077
Instrument Name:Agilent 6540 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:The 6540 QTOF/MS Detector (Agilent) operated in both positive and negative ESI mode in a detection range of 50 to 1700 m/z at 2 GHz in extended dynamic range. The DualAJS ESI source was set to the following parameters: Gas temperature 200 °C, drying gas 8 L/min, nebulizer 35 psig, sheath gas temp: 350 °C, sheath gas flow 11 L/min, VCAp 3500 V and nozzle voltage of 0 V. Online calibration of the instrument was performed throughout the data acquisition using Agilent ES-TOF Reference Mass Solution Kit. Chromatograms were generated by the LC-MS instrument in .d format. Raw data were converted into mzXML and chromatogram peaks were extracted using XCMS v1.42.0 (https://pubs.acs.org/doi/10.1021/ac051437y), which was optimized using the IPO R package (https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-015-0562-8) with the following settings: peakwidth=c(10, 70), ppm= 20, snthresh=10, mzdiff=0.0034, prefilter=c(3, 100), noise=100, gapInit=0.8448, gapExtend=2.0544, bw=5, mzwid=0.015, minfrac=0.5, max=50. All further analyses were performed in R programming language, Metaboanalyst 4.0 (https://www.nature.com/articles/nprot.2011.319), and GraphPad Prism version 5.0 (GraphPad Software). IDEOM software (http://mzmatch.sourceforge.net/ideom.php; https://academic.oup.com/bioinformatics/article/28/7/1048/210126) was used to eliminate noise and for putative peak annotation by exact mass within ±10 ppm against the Metabolomic Discoveries in house metabolite library (https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0125044) in negative and positive ESI mode, respectively. Retention time prediction was applied to aid metabolite annotation.
Ion Mode:UNSPECIFIED
  logo